|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Aptuit
gptkb:Cyprotex
gptkb:DeveloGen
gptkb:Euprotec
gptkb:Just_Biotherapeutics
gptkb:Kinaxo_Biotechnologies
gptkb:Renovis
Oxford Asymmetry International
|
|
gptkbp:CEO
|
gptkb:Werner_Lanthaler
|
|
gptkbp:collaboratesWith
|
gptkb:Pfizer
gptkb:Takeda
gptkb:Bayer_AG
gptkb:Novo_Nordisk
gptkb:Sanofi
gptkb:Bristol_Myers_Squibb
|
|
gptkbp:country
|
gptkb:Germany
|
|
gptkbp:focusesOn
|
precision medicine
biologics
drug discovery
drug development
gene therapy
small molecules
|
|
gptkbp:founded
|
1993
|
|
gptkbp:founder
|
gptkb:Manfred_Eigen
gptkb:Karsten_Henco
gptkb:Ulrich_Aldag
gptkb:Charles_Weissmann
Wolfgang Rutten
|
|
gptkbp:headquartersLocation
|
gptkb:Hamburg,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Evotec SE
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
DE0005664809
|
|
gptkbp:legalForm
|
gptkb:Societas_Europaea_(SE)
|
|
gptkbp:listedOn
|
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:numberOfEmployees
|
over 4,000
|
|
gptkbp:products
|
drug development services
drug discovery services
|
|
gptkbp:revenue
|
€751.4 million (2022)
|
|
gptkbp:stockExchange
|
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:EVT
|
|
gptkbp:subsidiary
|
Just – Evotec Biologics
|
|
gptkbp:tradedOn
|
gptkb:MDAX
gptkb:TecDAX
|
|
gptkbp:website
|
https://www.evotec.com/
|
|
gptkbp:bfsParent
|
gptkb:Cord_Dohrmann
gptkb:Just_Biotherapeutics
gptkb:Werner_Lanthaler
|
|
gptkbp:bfsLayer
|
8
|